Recent Posts in PPI Category
Posted on May 16, 2012 By Pharmaceutical Injury Attorney
David Brennan, CEO of AstraZeneca, is leaving his position following a dramatic drop in the company's performance. Investors have recently become discontent with the performance of the company. ...
Continue reading "AstraZeneca CEO Steps Down as Earnings Fall" »
Posted on Mar 12, 2012 By Pharmaceutical Injury Attorney
Health care systems are overburdened, according to some lawmakers. That is why the FDA is considering waiving the need for prescription for many diabetes and cholesterol medications. By eliminating ...
Continue reading "Will New Legislation Permit Over-the-Counter PPIs?" »
Posted on Feb 8, 2012 By Dangerous Drug Lawyer
The Proton Pump Inhibitor (PPI) class of pharmaceutical drugs has been revealed to cause yet another serious health issue for its users. PPIs, which include brand name drugs such as Nexium, Prilosec, ...
Continue reading "New FDA Warning Urges Caution in Use of PPIs" »
Posted on Feb 3, 2012 By Pharmaceutical Injury Attorney
Popular Proton Pump Inhibitors (PPIs), used to treat heartburn, acid reflux, and ulcers, were found to increase the risk of hip fractures in women smokers who take them. The study was performed by ...
Continue reading "Heartburn Drugs Increase Hip Fractures in Smokers" »